PNR
54
3
XYL
35
2
ES
45
-4
C
84
2
D
35
-6
NOV
55
3
PRU
60
-2
PFE
45
12
WY
56
2
YUM
58
2
VIX
19
-6
FSLR
78
5
ESS
47
7
NWSA
79
15
VRSK
32
2
CVX
28
3
EMR
67
3
HIG
70
2
VTR
69
2
BAC
80
3
PNR
54
3
XYL
35
2
ES
45
-4
C
84
2
D
35
-6
NOV
55
3
PRU
60
-2
PFE
45
12
WY
56
2
YUM
58
2
VIX
19
-6
FSLR
78
5
ESS
47
7
NWSA
79
15
VRSK
32
2
CVX
28
3
EMR
67
3
HIG
70
2
VTR
69
2
BAC
80
3
Financhill
Back

Publicis Groupe SA Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Buy
62

PUBGY
Publicis Groupe SA

Last Price:
$25.84
Seasonality Move:
4.96%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$37.17
Seasonality Move:
-16.78%
Buy
62
Publicis Groupe SA (PUBGY) is a Buy

Is Publicis Groupe SA a Buy, Sell or Hold?

  • The current Publicis Groupe SA [PUBGY] share price is $25.84. The Score for PUBGY is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • PUBGY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PUBGY Stock Price Chart

What is Publicis Groupe SA's stock price today?

  • The Publicis Groupe SA share price today is $25.84
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PUBGY is experiencing slight selling pressure.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

PUBGY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.75 Buy
Relative Strength Index (14 RSI): 60.09 Buy
Chaikin Money Flow: -101896 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.23 - 25.69) Buy
Bollinger Bands (100): (23.24 - 25.24) Buy

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

PUBGY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.86 Sell
20-day SMA: 25.12 Buy
50-day SMA: 24.98 Buy
200-day SMA: 24.93 Buy
8-day EMA: 16.4 Buy
20-day EMA: 8.54 Buy
50-day EMA: 3.83 Buy
200-day EMA: 1.01 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

Publicis Groupe SA Earnings Growth & PUBGY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.27 per share, and an increase next year of $0.12 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

Publicis Groupe SA Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):